+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 75Years
All Genders
ID06062927

Model Using Geno-radiomics to Evaluate Response and Predict Outcomes of Immunotherapy and Targeted Therapy in Advanced Soft Tissue Sarcoma

Led by Peking Union Medical College Hospital · Updated on 2023-10-02

60

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying advanced soft tissue sarcoma STS, a type of cancer, to evaluate how well a new combined immunotherapy and targeted therapy works. This study uses a new imaging analysis technique called radiomics to analyze CT and MRI scans along with genetic, histological, inflammatory, and immune cell data. The goal is to create a reliable model that predicts how patients respond to treatment and their prognosis, helping to identify those who may benefit from this therapy. Participants will receive a combination of small molecule multi-target tyrosine kinase inhibitors TKI and immunotherapy drugs targeting PD-1 or PD-L1. The study collects imaging data, tumor tissue samples, and clinical information before and after treatment. Radiomic parameters from imaging are combined with genetic sequencing and immune system markers to build the predictive model. Patients must have measurable disease and agree to the treatment and follow-up procedures. During the study, participants will undergo imaging scans, tumor tissue collection, blood tests, and immune cell analyses to monitor treatment response and disease progression. Researchers will assess the accuracy of the radiomics-based model in predicting treatment outcomes and prognosis over at least 42 months. Participants will be monitored closely for safety and adherence throughout the trial period, which may last several years.

CONDITIONS

Brief Title

Geno-radiomics Based Model for Evaluation of Immunotherapy and Targeted Therapy for Advanced Soft Tissue Sarcoma

Research Team

X

Xiang Wang

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here